Analysed Vivos Therapeutics Inc (VVOS:NASDAQ) News Sources
Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference
Yahoo Finance
Intellia Therapeutics, Inc.: Intellia Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Updates
FinanzNachrichten.de
BrainStorm Cell Therapeutics Inc.: Brainstorm Cell Therapeutics Secures Second $1 Million Strategic Placement; Total $2 Million Raised In February
FinanzNachrichten.de
Brainstorm Cell Therapeutics Secures Second $1 Million Strategic Placement; Total $2 Million Raised In February
Medindia
Pfizer Nabs Exclusive Rights to In Vivo Base-Editing Program in Pact With Beam Therapeutics
Precision Medicine Online
Kymera Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
Markets Insider
What is the current price of Vivos Therapeutics Inc (VVOS:NASDAQ)?
The current price of Vivos Therapeutics Inc (VVOS:NASDAQ) is $1.45.
Vivos Therapeutics Inc (VVOS:NASDAQ) absolute price change since previous trading day?
The absolute price change of Vivos Therapeutics Inc (VVOS:NASDAQ) since the previous trading day is $-0.02.
Vivos Therapeutics Inc (VVOS:NASDAQ) percentage price change since previous trading day?
The percentage price change of Vivos Therapeutics Inc (VVOS:NASDAQ) since the previous trading day is -1.36%.
What is This Week's average sentiment score for Vivos Therapeutics Inc (VVOS:NASDAQ)?
This Week's average sentiment score for Vivos Therapeutics Inc (VVOS:NASDAQ) is 88 out of 100.
What is This Week's average sentiment for Vivos Therapeutics Inc (VVOS:NASDAQ)?
This Week's sentiment for Vivos Therapeutics Inc (VVOS:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.